Bolt Biotherapeutics, Inc. — Director's Dealing 2021

Feb 4, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Bolt Biotherapeutics, Inc. (BOLT)
CIK: 0001641281
Period of Report: 2021-02-04

Reporting Person: Khanna Ashish Siri Ram (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$4.34	2030-09-10	Common Stock (10000)		Indirect

Footnotes

F1: For so long as Reporting Person's spouse continuously provides services to the Issuer (or any subsidiary or parent of the Issuer) as an employee, officer, director, contractor or consultant, through the applicable vesting dates, this Option will vest and become exercisable as follows: (a) prior to November 11, 2019 (the "Vesting Commencement Date"), this option will not be vested or exercisable as to any of the shares subject to the option; and (b) following the Vesting Commencement Date, this option will become vested and exercisable with respect to 1/48th of the shares subject to the option when the Reporting Person's spouse completes each month of continuous service following the Vesting Commencement Date.